title: The ODAC Chronicles: Part 3. The FDA's philosophy and process for cancer drug evaluation and approval.
authors.forename: Antonio J
authors.initials: AJ
authors.lastname: Grillo-López
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D008389:Marketing of Health Services; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents